Introduction: Primary polydipsia, frequently observed in patients with schizophrenia, can cause severe hyponatremia, leading to serious complications. Objective: This study reviews the management and prevalence of psy...Introduction: Primary polydipsia, frequently observed in patients with schizophrenia, can cause severe hyponatremia, leading to serious complications. Objective: This study reviews the management and prevalence of psychogenic polydipsia, focusing on treatments and clinical outcomes. Methods: Following the PRISMA guidelines, studies on polydipsia in psychiatric patients were included. Data were extracted from databases such as PubMed and Scopus, and a meta-analysis was performed. Results: Fifteen studies were analyzed, totaling 586 patients. The use of urea was effective in correcting hyponatremia, while antipsychotics showed mixed results. Heterogeneity between studies was moderate (I2 = 56%). Conclusion: Psychogenic polydipsia is a severe condition in schizophrenic patients. The use of urea has shown promise, but further studies are needed to optimize treatments.展开更多
We report a case of severe hyponatremia related to duloxetine and ziprasidone. A 50-year-old woman on duloxetine and ziprasidone treatment for major depressive disorder developed polydipsia, polyuria, and two episodes...We report a case of severe hyponatremia related to duloxetine and ziprasidone. A 50-year-old woman on duloxetine and ziprasidone treatment for major depressive disorder developed polydipsia, polyuria, and two episodes of seizures, followed by admission to the emergency department on the 10th day of treatment. Laboratory investigations revealed elevated creatine kinase （CK） as well as hyponatremia, hypo-osmolality, and increased urine sodium. Syndrome of Inappropriate Antidiuretic Hormone （SIADH） was considered, although urine osmolality was not measured. Duloxetine and ziprasidone were discontinued and the CK gradually normalized after correction of hyponatremia. Clinicians should be aware of the possibility of antipsychotic-induced hyponatremia, particularly in patients with symptoms of polydipsia.展开更多
文摘Introduction: Primary polydipsia, frequently observed in patients with schizophrenia, can cause severe hyponatremia, leading to serious complications. Objective: This study reviews the management and prevalence of psychogenic polydipsia, focusing on treatments and clinical outcomes. Methods: Following the PRISMA guidelines, studies on polydipsia in psychiatric patients were included. Data were extracted from databases such as PubMed and Scopus, and a meta-analysis was performed. Results: Fifteen studies were analyzed, totaling 586 patients. The use of urea was effective in correcting hyponatremia, while antipsychotics showed mixed results. Heterogeneity between studies was moderate (I2 = 56%). Conclusion: Psychogenic polydipsia is a severe condition in schizophrenic patients. The use of urea has shown promise, but further studies are needed to optimize treatments.
文摘We report a case of severe hyponatremia related to duloxetine and ziprasidone. A 50-year-old woman on duloxetine and ziprasidone treatment for major depressive disorder developed polydipsia, polyuria, and two episodes of seizures, followed by admission to the emergency department on the 10th day of treatment. Laboratory investigations revealed elevated creatine kinase （CK） as well as hyponatremia, hypo-osmolality, and increased urine sodium. Syndrome of Inappropriate Antidiuretic Hormone （SIADH） was considered, although urine osmolality was not measured. Duloxetine and ziprasidone were discontinued and the CK gradually normalized after correction of hyponatremia. Clinicians should be aware of the possibility of antipsychotic-induced hyponatremia, particularly in patients with symptoms of polydipsia.
